Search - tctmd.com

Displaying 41 - 60 of 346

Sort: Relevancy | Date

News Daily News

FDA Approves Colchicine for Decreasing CV Events

Caitlin E. Cox

June 20, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Conference News SCAI 2023

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

L.A. McKeown

May 22, 2023

News Daily News

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Michael O'Riordan

May 03, 2023

News Daily News

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Michael O'Riordan

March 31, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Conference News ACC 2023

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Caitlin E. Cox

March 14, 2023

News Conference News ACC 2023

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Yael L. Maxwell

March 09, 2023

News Conference News ACC 2023

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Michael O'Riordan

March 09, 2023

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Shelley Wood

March 04, 2023

News Daily News

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Michael O'Riordan

February 16, 2023

News Opinion CV Team Dispatch

February 2023 News Roundup

L.A. McKeown

February 15, 2023

News Opinion CV Team Dispatch

January 2023 News Roundup

L.A. McKeown

January 16, 2023

News Daily News

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Michael O'Riordan

November 17, 2022

News Conference News AHA 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

Shelley Wood

November 06, 2022

News Daily News

New Biomarker-Based Risk Score Performs Well in ACS

Michael O'Riordan

October 25, 2022

News Conference News ESC 2022

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Shelley Wood

August 28, 2022

News Daily News

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

Yael L. Maxwell

June 03, 2022

News Conference News EAS 2022

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Michael O'Riordan

May 24, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

Advertisement

FDA Approves Colchicine for Decreasing CV Events

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Longer-Term ASCVD Risk Assessment Best for Younger Patients

February 2023 News Roundup

January 2023 News Roundup

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

New Biomarker-Based Risk Score Performs Well in ACS

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content